SELECTIS HEALTH, INC. (GBCS): Entry into a Material Definitive Agreement
SELECTIS HEALTH, INC. (GBCS) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-2.1 2 ex2-1.htm EX-2.1 Exhibit 2.1 Execution Version AGREEMENT AND PLAN OF MERGER by and among BLACK PEARL EQUITIES II, LLC, TORTUGA ACQUISITION SUB, INC. and SELECTIS HEALTH, INC. Dated as of June 18, 2026 Table of Contents Page ARTICLE I DEFINITIONS 2 SECTION 1.01 Definition
How this was made
The 30-second read
Why it matters
The disclosed $5.75 per-share cash offer is the key valuation anchor; subsequent trading will likely reflect deal-arbitrage positioning, tender progress, and any conditions to closing.
Market read
Primary disclosure of a cash buyout price and transaction structure typically re-prices the target’s stock toward the offer price and creates deal-spread trading opportunities.
What to watch
Traders should monitor tender acceptance timing, any top-up option mechanics, and the debt commitment/financing conditions referenced in the agreement for potential delays or renegotiation risk.
Background
The SEC 8-K reports entry into a material definitive agreement: a tender offer followed by a merger, with the company board unanimously approving and recommending acceptance.
Ticker impact
Selectis Health entered a material definitive merger agreement, with a tender offer to buy all shares at $5.75 per share in cash.
Shares may trade toward the $5.75 offer price (or reflect deal spread) as investors price tender/closing risk and timing.
This is a primary SEC 8-K disclosure of an agreement and offer price; the most actionable datapoint for the stock is the stated $5.75 per-share cash consideration.
Market effects
Limited sector read-through; this is company-specific M&A rather than a sector-wide catalyst.
Minimal broader regional impact expected; focus remains on the target’s deal spread and financing/tender mechanics.
Low global relevance; cross-border effects not indicated in the provided text.
Counterpoint
Even with a stated offer price, closing risk (financing conditions, regulatory approvals, or termination rights) can keep the stock below the offer price and widen the deal spread.
Key entities
- public_companySELECTIS HEALTH, INC.
Target company entering a definitive merger agreement and tender offer at $5.75 per share cash.
- acquirerBLACK PEARL EQUITIES II, LLC
Purchaser party to the merger agreement that will cause a tender offer and fund the transaction via debt financing.
- merger_subTORTUGA ACQUISITION SUB, INC.
Wholly owned subsidiary of the purchaser that will commence the tender offer and merge into the company.
